Thymosin Treatment Modulates Production of Interferon
- 1 January 1981
- journal article
- research article
- Published by Mary Ann Liebert Inc in Journal of Interferon Research
- Vol. 1 (3), 411-420
- https://doi.org/10.1089/jir.1981.1.411
Abstract
The maturation of T lymphocytes, the major producers of gamma interferon (IFN- γ), is regulated by thymic hormones. These studies were undertaken to determine whether or not thymic hormones also regulate the production of interferons by C57B1/6 mice. The results clearly indicate an important interrelationship between thymosin and production of interferon. Subcutaneous injection of a single dose of 100 μg or 200 μg of thymosin fraction 5 approximately 40 hr before induction of interferon with Newcastle disease virus (NDV) significantly augmented serum interferon titers compared to the interferon titers induced in untreated mice. Maximum enhancement was observed when a single injection of thymosin fraction 5 was administered between 6 and 12 hr before NDV. Two purified thymosin polypeptides,α1 which induces maturation of helper T cells and α7 which induces maturation of suppressor T cells, had opposite effects. Three injections of 5 μg of thymosin α1 administered before NDV increased production of interferon while 3 daily injections of 1 μg of thymosin α7, suppressed the responsiveness of mice to NDV. This observation represents the first report of a direct effect of purified thymic hormones on the production of interferon. Thymosin fraction 5 also enhanced production of IFN- γ. Enhanced interferon production was observed in Concanavalin A (Con A)-stimulated cultures of spleen cells from mice treated in vivo with 150 pg of thymosin fraction 5. The circadian rhythm of thymosin α1 levels and the titer of interferon induced conincided. Significantly higher titers of interferon were induced when NDV was injected at midnight than were induced when NDV was injected in the morning. The results of this study suggest a significant role for the endocrine thymus in modulating interferon production and provide a rationale for exploring the role of thymosin in the treatment of viral diseases and perhaps other infectious diseases.This publication has 20 references indexed in Scilit:
- The circadian rhythm of thymosin therapy during acute reovirus type 3 infection of neonatal miceClinical Immunology and Immunopathology, 1980
- CURRENT STATUS OF THYMOSIN RESEARCH: EVIDENCE FOR THE EXISTENCE OF A FAMILY OF THYMIC FACTORS THAT CONTROL T‐CELL MATURATION*Annals of the New York Academy of Sciences, 1979
- The in vitro induction of differentiation of putative human stem cells by thymosin and agents that affect cyclic AMPClinical Immunology and Immunopathology, 1978
- Interferon production by individual cells in cultureVirology, 1977
- Fluorescence-activated cell sorting of human T and B lymphocytes: II. Identification of the cell type responsible for interferon production and cell proliferation in response to mitogensCellular Immunology, 1974
- DIFFERENTIATION OF T CELLS INDUCED BY PREPARATIONS FROM THYMUS AND BY NONTHYMIC AGENTSThe Journal of Experimental Medicine, 1973
- EFFECTS OF THE THYMUS LYMPHOCYTOPOIETIC FACTOR*Annals of the New York Academy of Sciences, 1966
- Effect of a Lipid Fraction from Rat Thymus on Delayed Hypersensitivity Reactions of Neonatally Thymectomized RatsNature, 1965
- Activity of a noncellular calf thymus extract in normal and thymectomized miceLife Sciences, 1963
- The Lymphocytosis Stimulating Factor (L.S.F.)Experimental Biology and Medicine, 1962